ir-world-logo irw-world-logo-bogen
facebook-logo youtubelogo twitterlogo googlepluslogo rsslogo linkedinlogo pinterestlogo xinglong
Naturally Splendid Enterprises Ltd. 09.03.2015

Naturally Splendid USA Provides
Cannabigerol (CBGa) Biosynthesis Overview
 

VANCOUVER, British Columbia, March, 9th 2015 - Naturally Splendid Enterprises (the "Company") (TSX-V: NSP) (OTCQB: NSPDF) (Frankfurt: 50N) is pleased to provide the following update.

The Company is currently identifying multiple opportunities emerging from the recently acquired access to technologies from FSL Laboratories (FSL). Naturally Splendid CEO Craig Goodwin reports, “With the appointment of Mr. Racz as President of Naturally Splendid USA, we are now positioned to begin the process of monetizing the technologies we recently received from FSL. One of the opportunities in front of us is the potential to biosynthetically produce pharmaceutical grade cannabinoids without having to grow  a single plant and thus potentially lowering the cost of production significantly, creating a competitive advantage over traditional extraction and formulation technologies This technology may be applied in the development of food, beverage and nutraceutical/cosmetic products and eventually for pharmaceutical applications”.

In this regards, the Company is pleased to report they have retained the services of Ms. Katie Schmitt, from Boreal Technologies. Ms. Schmitt will be directly involved in the transfer of technological expertise obtained under the agreement from FSL and implementation of commercialization strategies as the Company continues to progress with its plans to penetrate the evolving global opportunities. Naturally Splendid will license, develop, market and distribute cannabinoid products and technologies only in jurisdictions where these products are legal. The Company would like to emphasize that in accordance with regulatory direction provided by the TSX, the Company will obtain legal opinions of emerging business opportunities upon Exchange request.


Naturally Splendid VP of Operations Bryan Carson reports, “We are pleased to have Ms. Schmitt join the Naturally Splendid team as we process the multiple monetary opportunities surrounding our recent agreement with FSL. There is no better way to advance these opportunities than to retain key personal within Boreal to assist us in driving multiple revenue opportunities. This is further proof of the existing and in fact, the continued strengthening of the relationship between FSL / Boreal and Naturally Splendid”.

Ms. Schmitt reports, FSL has filed a patent application covering the organic and enzymatic synthesis of cannabinoids. This technology will allow for industrial scale production of cannabinoids catalyzed from Cannbigerolic acid (CBGa) without the requirement to grow large quantities of plants. The process mimics the natural synthesis that occurs in the plant’s bio-pathway. Cannabinoids produced in the bioreactor are pharmaceutical grade purity (>99%) and devoid of by-products and impurities. The largest advantages with this technology over existing methods of cannabinoid production (natural and synthetic) are: its low price per unit manufacturing costs (potentially 1/10th to 1/3rd the cost of existing methods); its ability to produce a diversity of products from a single manufacturing line; and commercial scalability. It also creates access to lesser known cannabinoids for research and analysis of their potential therapeutic applications.
 

NSP will identify licensed partners in legal jurisdictions that it can collaborate with to develop safe and efficacious cannabinoid therapies utilizing this technology. Potential therapeutic applications include: Analgesic – Relieves pain; Antibacterial – Slows bacterial growth; Anti-inflammatory – Reduces inflammation systemically; and Anti-Proliferative – May Inhibit cancer cell growth through apoptosis.

 

 

About Naturally Splendid Enterprises Ltd.

 

Naturally Splendid has an exclusive licensing agreement to market and distribute, the full complement of patent pending, plant-based omega products created by Boreal Technologies. The products include HempOmega™ and H2Omega™, as well as the AlgaeOmega™ FlaxOmega™, CanolaOmega™, and ChiaOmega™ plant based omega products. These novel products utilize microencapsulation and are available in both a powder format and an aqueous solution for increased flexibility in ingredient applications and stand-alone products. Additionally, the Company has licensed from FSL progressive cannabinoid extraction and formulation technologies including the world’s first water soluble cannabinoid patent.

 

Naturally Splendid's 100% owned NATERA™ line of hemp-based superfood products are carried nationwide by Canada's leading health food distributors and a network of retail stores across Canada including major retailers and specialty stores. Naturally Splendid's recently rebranded "NATERA™" line of products includes natural and flavored shelled hemp seeds as well as natural and flavored hemp protein powders.

 

About Full Spectrum Labs Limited.

 

Full Spectrum Laboratories, LTD. incorporated in Ireland, is a bioresearch and product development company with operating subsidiaries in Canada and the United States. The company has principally focused on the plant cannabis sativa and has developed numerous technologies and made several discoveries resulting in two granted patents and over 11 patent applications, in just under 5 years. FSL currently concentrates on formulation and extraction technologies; analytical cannabis testing in Canada; advance cannabis plant breeding specializing in CBD expression; and cannabinoid bio-synthesis.

 

For more information e-mail info@naturallysplendid.com or call 604-673-9573

 

On Behalf of the Board of Directors


J. Craig Goodwin

CEO, Director

 

Contact Information

Naturally Splendid Enterprises Ltd.

(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)

2435 Beta Avenue
Burnaby, BC, V5C 5N1

Phone: (604) 570-0902

Fax:     (604) 570-0934

E-mail: info@naturallysplendid.com

Website: www.naturallysplendid.com

 

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid's control. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

 

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

 

> Naturally Splendid Enterprises Ltd., weitere Meldungen...
smallcap-investor-logo
investor-sms-logo
irw-press-logo